Phase I trial of sequential paclitaxel and cisplatin in combination with the cyclin dependent kinase inhibitor flavopiridol (flavo) in patients with advanced solid tumors.

被引：0
|
作者：
Schwartz, GK
Kaubisch, A
Saltz, L
Ilson, D
O'Reilly, E
Barazzuol, J
Endres, S
Stoltz, M
Tong, W
Kelsen, DP
Spriggs, D
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
[2] Hoechst Marion Roussel Inc, Kansas City, MI USA
来源：
CLINICAL CANCER RESEARCH | 1999年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
122
引用
收藏
页码：3754S / 3754S
页数：1
相关论文
共 50 条
  • [1] Phase I study of the cyclin-dependent kinase inhibitor flavopiridol in combination with paclitaxel in patients with advanced solid tumors
    Schwartz, GK
    O'Reilly, E
    Ilson, D
    Saltz, L
    Sharma, S
    Tong, W
    Maslak, P
    Stoltz, M
    Eden, L
    Perkins, P
    Endres, S
    Barazzoul, J
    Spriggs, D
    Kelsen, D
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (08) : 2157 - 2170
  • [2] Phase I trial of the cyclin-dependent kinase inhibitor flavopiridol in combination with docetaxel in patients with metastatic breast cancer
    Tan, AR
    Yang, XW
    Berman, A
    Zhai, SP
    Sparreboom, A
    Parr, AL
    Chow, C
    Brahim, JS
    Steinberg, SM
    Figg, WD
    Swain, SM
    CLINICAL CANCER RESEARCH, 2004, 10 (15) : 5038 - 5047
  • [3] Phase I trial of the cyclin-dependent kinase inhibitor and protein kinase C inhibitor 7-hydroxystaurosporine in combination with fluorouracil in patients with advanced solid tumors
    Kortmansky, J
    Shah, MA
    Kaubisch, A
    Weyerbacher, A
    Yi, S
    Tong, W
    Sowers, R
    Gonen, M
    O'Reilly, E
    Kemeny, N
    Ilson, DI
    Saltz, LB
    Maki, RG
    Kelsen, DP
    Schwartz, GK
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (09) : 1875 - 1884
  • [4] Phase I trial of cabazitaxel plus cisplatin in patients with advanced solid tumors.
    Lockhart, Albert C.
    Sundaram, Shankar
    Sarantopoulos, John
    Mita, Monica M.
    Lane, Alex R.
    Moseley, Jennifer L.
    Dedieu, Jean-Francois
    Stash, Diane
    Zhi, Xin
    Mazuir, Florent
    Mita, Alain C.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [5] A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridol
    Dickson, Mark A.
    Shah, Manish A.
    Rathkopf, Dana
    Tse, Archie
    Carvajal, Richard D.
    Wu, Nian
    Lefkowitz, Robert A.
    Gonen, Mithat
    Cane, Lauren M.
    Dials, Heather J.
    Schwartz, Gary K.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (06) : 1113 - 1121
  • [6] Phase I study of olaparib in combination with carboplatin and/or paclitaxel in patients with advanced solid tumors.
    van der Noll, Ruud
    Ang, Joo Ern
    Jager, Agnes
    Marchetti, Serena
    Mergui-Roelvink, Marja
    De Bono, Johann Sebastian
    Lolkema, Martijn
    Brunetto, Andre
    Arkenau, Hendrik-Tobias
    De Jonge, Maja J.
    van der Biessen, Diane
    Tchakov, Ilian
    Bowen, Karin
    Schellens, Jan H. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridol
    Mark A. Dickson
    Manish A. Shah
    Dana Rathkopf
    Archie Tse
    Richard D. Carvajal
    Nian Wu
    Robert A. Lefkowitz
    Mithat Gonen
    Lauren M. Cane
    Heather J. Dials
    Gary K. Schwartz
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 1113 - 1121
  • [8] Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumors
    Stathis, A.
    Hess, D.
    von Moos, R.
    Homicsko, K.
    Griguolo, G.
    Joerger, M.
    Mark, M.
    Ackermann, C. J.
    Allegrini, S.
    Catapano, C. V.
    Xyrafas, A.
    Enoiu, M.
    Berardi, S.
    Gargiulo, P.
    Sessa, C.
    INVESTIGATIONAL NEW DRUGS, 2017, 35 (06) : 766 - 772
  • [9] Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumors
    A. Stathis
    D. Hess
    R. von Moos
    K. Homicsko
    G. Griguolo
    M. Joerger
    M. Mark
    C. J. Ackermann
    S. Allegrini
    C. V. Catapano
    A. Xyrafas
    M. Enoiu
    S. Berardi
    P. Gargiulo
    C. Sessa
    Investigational New Drugs, 2017, 35 : 766 - 772
  • [10] Phase I clinical and pharmacokinetic trial of the cyclin-dependent kinase inhibitor flavopiridol
    Thomas, JP
    Tutsch, KD
    Cleary, JF
    Bailey, HH
    Arzoomanian, R
    Alberti, D
    Simon, K
    Feierabend, C
    Binger, K
    Marnocha, R
    Dresen, A
    Wilding, G
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 50 (06) : 465 - 472
12345